CUBT — Curative Biotechnology Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $10.02m
- $10.87m
Annual cashflow statement for Curative Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 0.207 | -4.67 | -5.34 |
| Depreciation | |||
| Non-Cash Items | -0.226 | 4.37 | 3.18 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.014 | 0.109 | 0.549 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Cash from Operating Activities | 0 | -0.19 | -1.6 |
| Capital Expenditures | 0 | -0.034 | -0.021 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Cash from Investing Activities | 0 | -0.034 | -0.021 |
| Financing Cash Flow Items | — | — | -0.093 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 0 | 0.385 | 2.14 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0 | 0.161 | 0.51 |